The present invention is directed to nanoparticulate compositions comprising topiramate. The topiramate particles of the composition have an effective average particle size of less than about 2 microns.
CROSS-REFERENCE TO RELATED APPLICATIONS
The present invention claims benefit of U.S. Provisional Application No. 60/444,377, filed on Jan. 31, 2003; U.S. Provisional Application No. 60/477,789, filed on Jun. 12, 2003; and U.S. Provisional Application No. 60/511,318, filed on Oct. 16, 2003.